StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 1,017.00
-2.00 (-0.20%)
Aug 1, 2025, 3:30 PM JST
StemCell Institute Company Description
StemCell Institute Inc. engages in the stem cell banking business in Japan.
The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses.
StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
StemCell Institute Inc.
| Country | Japan |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 117 |
| CEO | Takafumi Shimizu |
Contact Details
Address: 1-21-19, Toranomon Tokyo, 105-0001 Japan | |
| Phone | 81 3 6811 3230 |
| Website | stemcell.co.jp |
Stock Details
| Ticker Symbol | 7096 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3399640006 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Takafumi Shimizu | Chief Executive Officer |